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The purpose of this study was to describe the development of a clinical model for 
lung cancer patients treated with stereotactic body radiotherapy (SBRT) within 
a knowledge-based algorithm for treatment planning, and to evaluate the model 
performance and applicability to different planning techniques, tumor locations, 
and beam arrangements. 105 SBRT plans for lung cancer patients previously treated 
at our institution were included in the development of the knowledge-based model 
(KBM). The KBM was trained with a combination of IMRT, VMAT, and 3D CRT 
techniques. Model performance was validated with 25 cases, for both IMRT and 
VMAT. The full KBM encompassed lesions located centrally vs. peripherally 
(43:62), upper vs. lower (62:43), and anterior vs. posterior (60:45). Four separate 
sub-KBMs were created based on tumor location. Results were compared with the 
full KBM to evaluate its robustness. Beam templates were used in conjunction with 
the optimizer to evaluate the model’s ability to handle suboptimal beam placements. 
Dose differences to organs-at-risk (OAR) were evaluated between the plans gener-
ated by each KBM. Knowledge-based plans (KBPs) were comparable to clinical 
plans with respect to target conformity and OAR doses. The KBPs resulted in a 
lower maximum spinal cord dose by 1.0 ± 1.6 Gy compared to clinical plans, p = 
0.007. Sub-KBMs split according to tumor location did not produce significantly 
better DVH estimates compared to the full KBM. For central lesions, compared to 
the full KBM, the peripheral sub-KBM resulted in lower dose to 0.035 cc and 5 cc 
of the esophagus, both by 0.4Gy ± 0.8Gy, p = 0.025. For all lesions, compared to 
the full KBM, the posterior sub-KBM resulted in higher dose to 0.035 cc, 0.35 cc, 
and 1.2 cc of the spinal cord by 0.2 ± 0.4Gy, p = 0.01. Plans using template beam 
arrangements met target and OAR criteria, with an increase noted in maximum 
heart dose (1.2 ± 2.2Gy, p = 0.01) and GI (0.2 ± 0.4, p = 0.01) for the nine-field 
plans relative to KBPs planned with custom beam angles. A knowledge-based 
model for lung SBRT consisting of multiple treatment modalities and lesion loca-
tions produced comparable plan quality to clinical plans. With proper training and 
validation, a robust KBM can be created that encompasses both IMRT and VMAT 
techniques, as well as different lesion locations.
PACS number(s): 87.55de, 87.55kh, 87.53Ly
Key words: treatment planning, lung, SBRT, knowledge-based model 
 
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 6, 2016
263   263
264  Snyder et al.: Development and evaluation of lung SBRT knowledge-based model  264
Journal of Applied Clinical Medical Physics, Vol. 17, No. 6, 2016
I. INTRODUCTION
Stereotactic body radiotherapy (SBRT) has been shown to be an effective treatment method 
of medically inoperable, early stage, non-small cell lung cancer (NSCLC).(1-3) Several groups 
have shown the efficacy of lung SBRT, using a combination of different immobilization and 
planning techniques, including static field techniques such as 3D conformal and intensity-
modulated radiotherapy (IMRT), as well as rotational techniques such as dynamic conformal 
arc and volumetric-arc radiotherapy (VMAT). Each technique has its own advantages and 
disadvantages;(4-6) however, all of these planning techniques require skill and experience in 
order to create an optimal plan that achieves tumor conformity and geometric organ sparing.
IMRT is often used to treat lung SBRT, providing conformal tumor coverage while minimizing 
dose to surrounding organs at risk (OAR). Although IMRT optimization can be more forgiving 
to suboptimal beam placement and less user-dependent than forward planning, variability in 
IMRT planning still occurs and may be dependent on a planner’s skill.(7) Several groups have 
been working to improve IMRT plan quality by correlating patient geometric factors with dose 
distributions from previous plans.(8-11) Models can be generated from the mathematical correla-
tion of the geometry and dose data from each patient plan and be used to predict dose-volume 
histograms for a new patient geometry.(12,13) 
A knowledge-based dose-volume histogram (DVH) algorithm that estimates the DVH, then 
automatically generates objectives given patient and beam geometry, has been introduced com-
mercially (RapidPlan v13.5, Varian Medical Systems, Palo Alto, CA). The knowledge-based 
model (KBM) is built from existing clinical plans that have ideal tumor coverage and OAR doses. 
The KBM implemented within RapidPlan utilizes a principle component analysis (PCA)-based 
approach, in which the first and second order principle components are determined to account 
for variation in DVH parameters.(11) Previous groups have created and evaluated knowledge-
based models for head and neck(14) and advanced hepatocellular cancer.(15) Their results showed 
that knowledge-based plans were comparable in plan quality to clinical plans and improved 
pass rates of clinical objectives. In this study a KBM, within the RapidPlan software, was built 
based on treatment plans for lung cancer patients treated with SBRT. Applicability of the KBM 
to variable treatment techniques, beam arrangements, and tumor location was evaluated.
 
II. MATERIALS AND METHODS
A.  Patient plan characteristics and selection
All plans in this study were contoured using a 4DITV method to account for respiratory motion. 
All patients received a four-dimensional CT (4D CT) in which the internal tumor volume (ITV) 
was generated from the maximum intensity projection (MIP).(16) Contouring and planning was 
performed on the average CT postprocessed from the 4D CT. Planning tumor volumes (PTV) 
were expanded from the ITV using a uniform 3 mm margin for central lesions, and a 6 mm 
uniform margin for peripheral lesions. The PTV margins were manually modified by the physi-
cian in order to respect anatomical boundaries and avoid overlap between the PTV and critical 
OARs, such as the esophagus, heart, and brachial plexus. Overlap between the PTV and rib 
was ignored and the dose limit to the rib was often exceeded to achieve PTV dose coverage. 
Plans were prescribed to either 48 Gy or 36 Gy, 12 Gy per fraction. OARs were contoured and 
planned using dose constraints similar to RTOG 0915(17) with slight modifications (Table 1).
Plans were optimized in the Eclipse treatment planning system (Varian Medical Systems), 
using the anisotropic analytical algorithm (AAA) for final dose calculation. Typical beam 
setup for both IMRT and VMAT techniques used 6 MV, coplanar fields avoiding beams enter-
ing through the contralateral lung. IMRT plans consisted of 7–9 beams with 20°–35° between 
each field. VMAT plans consisted of two continuous partial arcs, approximately 120°–160° in 
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length. The start and stop gantry positions varied with patient geometry and lesion location. 
VMAT collimator angles were mirrored between the two partial arcs, where default collimator 
angles of 30° and 330° were utilized.
One hundred and five early stage lung SBRT plans previously treated at our institution 
were used in the model. All patients included in the model were included in an IRB-approved 
protocol at Henry Ford Hospital. From the database of lung patients treated with SBRT at our 
institution, plans were chosen that were considered well planned and met all OAR constraints. 
The 105 plans consisted of 97 IMRT, 6 VMAT, and 2 3D CRT plans. A large percentage of the 
lung SBRT plans treated at our institution were IMRT, and is reflected by the large percentage 
of IMRT cases included the model. Two 3D CRT cases were small peripherally located lesions, 
which were included to increase the range of tumor volumes accounted for in the model. Since 
the lesions were peripherally located, they were fairly isolated from the OARs and had minor 
impact on the dose estimation in the high-dose regions of the OAR’s DVH. 
Previous studies comparing IMRT and VMAT treatment planning for lung SBRT have 
found comparable PTV dose coverage and OAR dose sparing between the two treatment 
techniques.(5,6) Since the KBM correlates the geometrical relationship of the PTV and OAR 
to the DVH, due to the similarities in plan quality, IMRT and VMAT plans were included in a 
single model. Furthermore, an intertechnique, interinstitutional study for head and neck IMRT 
OAR modeling found that, if the same clinical criteria is used, a model can be interchanged 
between different treatment modalities such as IMRT and helical tomotherapy.(12)   
To ensure the model encompassed a variety of geometries, the training cases included a 
combination of 51 left- and 54 right-sided lesions; 40 upper, 22 mid, and 43 lower lobe cases; 
17 anterior, 45 posterior, and 43 midline lesions; and 43 central and 62 peripheral lesions. 
Central and peripheral lesions were classified according to RTOG criteria, in which lesions 
within 2 cm of the proximal bronchial tree were considered central.(17) The mean PTV was 
38.05 ± 30.75 cm3 (range: 3.93–202.47 cm3). 
Table 1. OAR dose constraints used for lung SBRT model for 12 Gy/fx plan in either 3 or 4 fractions.
    Max. Point Dose
 Organ Volume Volume Max.  (Gy)a
 Spinal Cord
 <0.35 cc 20.8 Gy 26 Gy    (5.2 Gy/fx) (6.5 Gy/fx)
  <1.2 cc 13.6 Gy   (3.4 Gy/fx)
 Esophagus <5 cc 18.8 Gy 30 Gy   (4.7 Gy/fx) (7.5 Gy/fx)
 Heart <15 cc 28 Gy 34 Gy   (7 Gy/fx) (8.5 Gy/fx)
 Total Lung - PTV <10% 20 Gy NA
 Ribs   <105% Rx
 Brachial Plexus <3 cc 23.6 Gy 27.2 Gy   (5.9 Gy/fx) (6.8 Gy/fx)
 Stomach <10 cc 17.6 Gy 27.2 Gy   (4.4 Gy/fx) (6.8 Gy/fx)
 Trachea <4 cc 15.6 Gy 34.8 Gy   (3.9 Gy/fx) (8.7 Gy/fx)
 Skin <10 cc 33.2 Gy 36 Gy   (8.3 Gy/fx) (9 Gy/fx)
a Maximum point dose defined as 0.035 cc.
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B.  Model training
Training of the model consists of evaluating the model fit and pinpointing plans that are outliers 
in order to improve the model fit within the given training set. Outliers are individual training 
plans or structures that differ from the average of the training set. Model training is an iterative 
process, requiring several iterations to resolve outliers (Fig. 1). Through the combination of the 
statistical indices and regression analysis between the model generated DVH estimate and the 
plan dose for each training plan, plans or structures that are greater than two standard devia-
tions from the average or considered to be influential data points in the model are identified as 
dosimetric or geometric outliers, respectively.(13) 
A dosimetric outlier is a training plan with different dosimetric characteristics than what 
was estimated by the model for the same plan. For each training plan, the model generates an 
estimated DVH range. The midpoint within the estimated DVH range is compared to the DVH 
of the training plan and deviations are flagged as outliers. A common instance of a dosimetric 
outlier occurred when the model estimated OAR doses were superior to the original plan. In 
these instances the training plan was replanned to achieve better dose sparing. Other dosimetric 
outliers were found to be caused by suboptimal beam placements or atypical OAR tradeoffs in 
the training plan. These plans were replanned and the patient plan reextracted.
A geometric outlier is a structure with different geometric characteristics than the average 
structure in the KBM. A common instance of a geometric outlier in the model occurred when 
structures were found to be contoured incorrectly, deviating from the RTOG guidelines. This 
occurred for only a handful of the cases, where a slice was missing from the contour or the 
superior/inferior extent of the contour was too short. This was discovered by the difference in 
the shape of the OAR’s DVH. Once the contour was fixed and verified by an attending physi-
cian, the data was reextracted with the new OAR contour.  
If the plan was neither a geometric or dosimetric outlier, the plan was evaluated to determine 
its fit within the model. If the plan did not represent the typical geometry or case type of the 
model, such as a case with multiple or differentially dosed lesions, it was removed. However, 
if the plan was deemed to be a common clinical case, additional plans that were similar were 
added into the model to ensure that the scope of the model included all desired clinical cases. 
After the addition or deletion of plans, all plan information was reextracted and used to rebuild 
and retrain the model. The OARs modeled in the KBM included the spinal cord, esophagus, 
heart, ribs, and normal lung (Total Lung–PTV). OARs such as the brachial plexus, stomach, 
and trachea that occurred less frequently clinically, were not modeled. In order to model an 
OAR, a minimum of 25 cases per OAR are needed.(18)
Fig. 1. Workflow and decision tree of model training.
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C.  Model validation
The model performance was validated on a validation plan set of 25 patient plans, independent 
from the training set. The patient geometries chosen in the validation plan set encompassed 
the range of geometries within the KBM. The validation plan set included a combination of 9 
left-sided lesions, 16 right-sided lesions; 12 upper, 4 mid, and 9 lower lobe cases; 9 anterior and 
16 posterior; and 10 central and 15 peripheral lesions. The mean PTV was 34.76 ± 30.10 cm3 
(range: 4.14–137.09 cm3). Each KBM was validated by applying it to the 25 validation plans 
and optimizing the plan with both IMRT and VMAT techniques. To avoid additional dosimetric 
variables during validation, the same beam arrangement initially designed by the dosimetrist in 
the clinical plan was used for the KBM validation. The optimization was run from start to finish 
with no planner intervention, including an intermediate dose calculation.(19) All KBPs were 
renormalized so that the coverage to D95% of the PTV remained the same as the clinical plan. 
Model validation consists of two parts: validation of the DVH estimation and the automated 
priorities. Figure 2 outlines the workflow used to validate the KBM. The DVH estimate from 
the KBM is given as a range (Fig. 3). The DVH estimate is compared by visually inspecting that 
the shape is similar and the range encompasses the DVH of the clinical plan. Figure 3 shows 
Fig. 2. Workflow of KBM validation.
Fig. 3. DVH of three oars: spinal cord (cyan), heart (orange), and esophagus,(21) demonstrating the DVH estimate, final 
calculated dose after optimization, the automatic generated line objective, and a manual objective.
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an example of a DVH with the estimate and line objective overlaid on the clinical DVH. If any 
large discrepancies occur between the estimate and the clinical DVHs, the model is deemed to 
have had insufficient training. 
The KBM uses the lower range of the DVH estimate as a line objective in the optimization, 
where the priority placed on the objective can be estimated by the KBM using the ratio between 
the weightings of the priorities of the PTV and the OARs. The automated priorities need to be 
validated to ensure that the weight relative to the PTV priority is sufficient so that OAR doses 
can be met without sacrificing PTV coverage. The automated priorities are validated by compar-
ing the knowledge-based plan (KBP) that was optimized with the automated priorities to the 
original plan and dose constraints. If the automated priority on the objective is sufficient, the 
KBP should achieve the line objective and meet OAR constraints. Manual objectives can also 
be included in the KBM to achieve OAR goals. In order to create a more flexible model that 
would be valid for other fractionation schemes, doses in the model were given in percentages 
of the prescription dose. 
Dose points on the lower range of the DVH estimate were identified to evaluate the different 
models, for the modeled OARs: spinal cord, esophagus, and heart. The conformity index (CI) 
and gradient index (GI) were used to compare the plans. The CI is defined as the ratio between 
the volume of the prescription dose and the volume of the target, whereas the gradient index 
(GI) is defined as the ratio between the volume of 50% of the prescription dose and the volume 
of target. The paired Student’s t-test was used to compare the plans, where the threshold used 
for statistical significance was p < 0.05.
D.  Tumor location
The geometrical distance between the target and OAR has been shown to correlate the amount 
of dose sparing achievable by an OAR.(8) The location of lesions differs in lung treatments due 
to the multiple lobes and consequently affects the relative geometrical relationship between 
the PTV and the OARs. The ability of the KBM to accurately estimate the DVH can be altered 
if all clinically applicable geometries and locations are not included and trained in the model. 
Ideally, one KBM that encompasses all geometries would be more streamlined and easier to 
use in a clinical setting; however, submodels may better estimate DVHs for the OARs. 
A total of five KBMs were created: a full KBM consisting of all lesion locations, central sub-
KBM (KBMC) consisting of centrally located lesions, peripheral sub-KBM (KBMP) consisting 
of peripherally located lesions, anterior sub-KBM (KBMANT) consisting of anterior lesions, and 
posterior sub-KBM (KBMPOST) consisting of posterior lesions. The sub-KBMs were compared 
to a full model (full KBM) to evaluate if it was necessary to create KBMs specific to the tumor 
location. To assess the differences between the sub-KBMs, the KBMs were validated on three 
set of validation plans: the full validation set with 25 plans containing lesions from all locations, 
and two subvalidation sets separated based on lesion location. 
The heart and esophagus structures are fairly midline relative to the lungs, whereas the spinal 
cord is located posteriorly. In a regression plot that correlates the geometric principal compo-
nent score (PCS) to the DVH PCS, the spinal cord structure from all training plans exhibited 
three distinct clusters (Fig. 4). The three clusters correlate to different tumor locations: anterior 
(magenta), midline (navy), and posterior (green). By splitting the anterior and midline lesions 
from the posterior lesions, the expected correlation between the DVH PCS and the geometric 
distribution PCS for the two subgroups, shown in the dotted lines, changes drastically. Thus, 
two spinal cord sub-KBMs were created to evaluate how the sub-KBMs change the spinal cord 
DVH estimation. KBMANT consists of anterior and midline lesions, which were included due to 
the relatively similar correlation between the PCSs, and KBMPOST which consists of posterior 
lesions. The KBMANT was trained with 71 cases and the KBMPOST was trained with 34 cases. 
The full KBM, KBMANT, and KBMPOST were validated with the full (25), anterior (9), and 
posterior (16) validation sets using an IMRT technique.
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The model was split into central (KBMC) and peripheral (KBMP) models, where central 
and peripheral lesions were defined according to RTOG 0915 criteria. Lesions categorized as 
central are within or touching the proximal bronchial tree.(17) The KBMC was trained with 43 
cases, and the KBMP with 62 cases. The validation set was also split into central and peripheral 
sets, where the full KBM, KBMC, and KBMP were validated on the full (25), central (10), and 
peripheral (15) validation sets using an IMRT technique.
E.  Dependency on beam arrangement 
The RapidPlan software is an IMRT/VMAT optimizer that optimizes the modulation of the 
delivered radiation beam in order to deliver a desired dose distribution. The quantity and 
placement of the beams are defined by the planner prior to optimization. For a given patient 
geometry, the beam arrangement may vary from planner to planner, resulting in slightly differ-
ent dose distributions. Beam angle optimizers have been used for IMRT treatment of non-small 
cell lung cancer to find optimal beam arrangements to further decrease dose to OARs.(20) The 
KBM takes into account the field geometry when estimating an OAR’s DVH, by parsing areas 
within and outside the treatment field. Because beam placement can affect the dose distribu-
tion and suboptimal beam placements can make optimization more difficult, the full KBM was 
validated using two fixed-beam IMRT templates in order to test the KBM’s ability to estimate 
OAR DVHs and automated priorities. If a suboptimal beam arrangement occurs, where a 
beam traverses through an OAR, the automated priorities may not be sufficient to achieve an 
acceptable OAR dose. 
Fig. 4. Spinal cord regression plot (top) showing three clusters corresponding to differing anterior to posterior locations 
in the lung (bottom). Magenta corresponds to anterior, blue corresponds to midline, and green corresponds to posterior. 
Dotted lines show expected correlation for the anterior and posterior sub-KBMs.
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Two fixed-beam IMRT templates used to validate the KBM included a seven- and a nine-field 
beam template. The seven-field beam template arranged beams roughly 25°–30° apart. For a 
right-sided tumor, the beam gantry angles were: 180°, 210°, 240°, 270°, 300°, 325°, 350°; and 
for a left-sided tumor, the beam gantry angles were: 180°, 150°, 120°, 90°, 60°, 35°, 10°. The 
nine-field beam template arranged beams approximately 20–25° apart. For a right-sided tumor, 
the beam gantry angles were: 180°, 205°, 230°, 255°, 280°, 305°, 330°, 350°, 10°; and for a 
left-sided tumor, the beam angles were: 180°, 155°, 130°, 105°, 80°, 55°, 30°, 10°, 350°. The 
nine-field beam template covered a larger range compared to the seven-field, and resulted in 
irradiating a larger portion of the heart and esophagus in a large majority of the validation cases.
Several studies have shown that the IMRT and VMAT techniques result in similar dose 
distribution. However for posterior lesions adjacent to the spinal cord, the majority of the cases 
at our institution are treated with posterior IMRT beams in order to obtain better conformity. 
VMAT delivery is limited by the machine limitation of the gantry unable to rotate past 180°. 
For posterior lesions, this limits the number of angles that a continuous arc can traverse. This 
can be bypassed if multiple posterior arcs are used; however, the VMAT delivery time increases 
as a result. Depending on the lesion location and difficulty of the case, VMAT can be used for 
posterior lesions. In order to support both IMRT and VMAT treatment techniques for posterior 
lesions in our model, additional VMAT posterior plans were added to the model to better train 
the model. The number of additional plans to add will vary from model to model, due to its 
dependence on the training set. The impact of any additional cases on the model can be gauged 
by assessing the regression plot and through revalidation of the new model.         
 
III. RESULTS 
A.  DVH estimation and automatic priorities
During validation of the automatic priorities, the automatic priority on the line objective for 
several OARs was insufficient to achieve the dose constraint for the maximum point dose, 
defined as 0.035 cc. Several manual point objectives were added to the model in order to reduce 
the maximum point dose for OARs to within the tolerance dose. Table 2 shows the final model 
objectives used in the model, including whether the model-generated DVH estimation automated 
priorities (KBMG) were used, or manual objective and priorities. 
The 25 cases validated with the full KBM for both IMRT and VMAT techniques met all 
OAR constraints. Table 3 shows the IMRT and VMAT validation results of the full KBM and 
the lower DVH estimates. KBM lower estimates for the heart and spinal cord were less than 
the clinical plan, confirming that the DVH estimation of the KBM was successful. Compared 
to the clinical IMRT plans, the IMRT KBM resulted in lower doses to 1.2, 0.35, and 0.035 cc 
of the spinal cord by 0.5 ± 0.9 Gy (p = 0.008), 0.8 ± 1.2 Gy (p = 0.004), and 1.0 ± 1.6 Gy (p = 
0.006), respectively. The VMAT estimate for 0.035 cc of the esophagus was greater than the 
VMAT clinical plan and the IMRT estimate. The VMAT KBM resulted in higher doses to the 
maximum point dose of the esophagus by 1.1 ± 2.2 Gy, p = 0.02. The CI between the clinical 
and KBP plans for both IMRT and VMAT were comparable. However, the GI increased in the 
IMRT KBPs compared to the clinical plans by 0.68 ± 0.57, p = 4.1E-6, and increased in the 
VMAT KBPs by 0.20 ± 0.34, p = 0.009.
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Table 2. Objectives and priorities used in the full model, including the objective type, the relative volume of the 
OAR in percent, the dose as a percent of the prescription dose, and the priority (unitless). The automatic objectives 
and priorities generated by the KBM are labeled as KBMG (knowledge-based model-generated), those with fixed 
numbers are manually added.
   Relative volume Dose
 Structure Objective type (%) (% of prescription) Priority
 
PTV
 Upper 0 109% 100
  Lower 100 100% 100
  Lower 98 100.5% 100
 Brachial Plexus Upper 0 50% 80
 Esophagus Line KBMG KBMG KBMG  Upper 0 35% 60
 Heart Line KBMG KBMG KBMG  Upper 0 48% 80
 Ribs Line KBMG KBMG 30  Upper 0 107% 0
 Spinal Cord Line KBMG KBMG KBMG  Upper 0 23% 75
 Stomach Upper 0 41% 80
 Total Lung-PTV Upper KBMG 20Gy 0
 Trachea Upper 0 71% 50
Table 3. Summary of OAR doses (Gy), CI, and GI from IMRT and VMAT validation, comparing the clinical plan 
and RapidPlan plan for 25 cases (mean ± SD) (Gy) and DVH estimates from the full KBM.
 IMRT Validation VMAT Validation
      Difference    Difference
    IMRT IMRT KBP –  VMAT VMAT KBP –
  Volume Clinical Estimate KBP Clinical Clinical Estimate KBP Clinical
 Structure (cc) (Gy) (Gy) (Gy) (Gy) (Gy) (Gy) (Gy) (Gy)
 Esophagus 5 5.7±4.2 5.9±3.6 5.4±3.7 -0.3±1.3 5.9±3.7 5.9±3.7 6.0±3.6 0.2±1.7
  0.035 10.4±5.8 10.0±4.8 10.3±5.5 -0.0±1.6 10.1±5.1 12.0±6.0 11.0±5.0 1.1±2.2a
 Heart 15 7.5±5.7 8.0±5.4 7.6±5.6 0.1±1.2 7.5±5.7 7.4±5.5 7.6±5.6 0.1±1.1
  0.035 13.2±9.9 10.5±7.6 13.3±9.9 0.1±1.6 12.5±9.3 12.4±9.0 12.6±9.3 0.1±0.8
 Spinal 1.2 7.6±2.9 7.3±2.8 7.1±2.5 -0.5±0.9a 7.2±3.1 7.0±2.8 7.1±2.8 -0.1±1.1
 Cord 0.35 8.6±3.4 8.2±3.3 7.8±2.9 -0.8±1.2a 7.9±3.4 7.8±3.3 7.8±3.0 -0.2±1.2
  0.035 9.4±4.0 8.8±3.5 8.4±3.3 -1.0±1.6a 8.7±3.9 8.7±3.5 8.4±3.3 -0.3±1.4
 CI 1.02±0.05 1.00±0.03  0.99±0.03 1.01±0.03
 GI 4.8±0.8 5.46±0.78  4.52±0.85 4.77±0.99
a Indicates a statistical difference (p < 0.05) between the KBP and clinical plan.
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B.  Tumor location
The final calculated doses for the esophagus, heart, and spinal cord from the five KBMs 
validated on full and subvalidation sets are shown in Table 4. When the model was divided 
according to central and peripheral locations and validated with the full validation set, com-
pared to the full KBM, the KBMP resulted in lower doses to 0.035 and 5 cc of the esophagus 
by 0.4 ± 0.8 Gy (p = 0.02) and 0.5 ± 0.6 Gy (p = 0.003), respectively. When validated with the 
subset of peripheral tumors, the full KBM, KBMC, and KBMP resulted in similar doses for all 
OARs. For the subset of central tumors, lower doses to 5 cc of the esophagus, by 0.5 ± 0.6 Gy 
(p = 0.025), were observed in the KBMP compared to the full KBM 
For the models divided according to anterior and posterior locations, KBMANT resulted in 
lower doses to 0.035, 0.35, and 1.2 cc of the spinal cord by 0.2 ± 0.4 Gy for all dose points 
(p = 0.02, 0.01, and 0.01, respectively), compared to the full KBM with the full validation set. 
Compared to the KBMPOST, the KBMANT resulted in higher doses to 0.035 cc of the esophagus 
by 0.4 ± 0.8 Gy, p = 0.02, as well as to 15 cc of the heart by 0.4 ± 0.8 Gy, p = 0.03. Whereas 
compared to the KBMANT, the KBMPOST resulted in higher doses to 0.035, 0.35, and 1.2 cc 
for the spinal cord by 0.3 ± 0.6 Gy (p = 0.007), 0.4 ± 0.6 Gy (p = 0.005), and 0.5 ± 0.7 Gy 
(p = 0.003), respectively. When validated on the posterior validation subset, compared to the 
KBMANT, the KBMPOST resulted in lower doses to 0.035 cc of the esophagus by 0.5 ± 0.8 Gy, 
p = 0.01. In the anterior validation subset, the KBMANT resulted in lower doses to 0.035, 0.35, 
and 1.2 cc of the spinal cord by 0.5 ± 0.4 Gy (p = 0.01), 0.5 ± 0.4 Gy (p = 0.009), and 0.5 ± 
0.5 Gy (p = 0.009), respectively, compared to the KBMPOST.
Table 4. Doses to esophagus, heart, and spinal cord from the full KBM and the four sub-KBMs divided by tumor 
location validated on the full and partial validation sets.
 Validation Esophagus Heart Spinal Cord
 Model Set 0.035 cc 5 cc 0.035 cc 15 cc 0.035 cc 0.35 cc 1.2 cc
 Full KBM Full 10.3±5.5 5.4±3.7 13.3±9.9 7.6±5.6 8.4±3.3 7.8±2.9 7.1±2.5
 KBMC Full 10.2±5.5 5.4±3.8 13.0±9.6 7.4±5.4 8.4±3.3 7.8±2.9 7.1±2.6
 KBMP Full 10.0±5.3
a 5.1± 3.5a 13.1±9.6 7.3±5.6 8.3±3.4 7.7±3.0 6.9±2.6
 KBMANT Full 10.6±5.8
b 5.2±3.6 13.4±9.9 7.7±5.7b 8.2±3.3a,b 7.6±2.9a,b 6.8±2.6a,b
 KBMPOST Full 10.2±5.4
b 5.3±3.8 13.0±9.6 7.3±5.4b 8.6±3.2b 8.0±2.9b 7.3±2.6a,b
 Full KBM Central 14.0±5.0 8.0±2.5 17.8±9.8 9.5±5.8 10.4±3.0 9.5±2.6 8.6±2.3
 KBMC Central 13.9±5.3 8.1±2.8 17.3±8.9 9.2±5.6 10.4±3.1 9.6±2.8 8.7±2.5
 KBMP Central 13.6±4.8 7.4±2.6
a 17.1±8.3 8.9±5.3 10.4±3.1 9.4±2.6 8.4±2.4
 Full KBM Peripheral 7.9±14.0 3.7±3.4 9.8±9.3 6.1±5.1 7.1±2.8 6.6±2.5 6.0±2.2
 KBMC Peripheral 7.7±18.9 3.6±3.3 9.7±9.0 6.0±5.1 7.1±2.7 6.6±2.4 6.0±2.2
 KBMP Peripheral 7.6±4.1 3.5±3.1 10.0±9.5 6.1±5.3 7.0±2.8 6.5±2.6 5.9±2.3
 Full KBM Anterior 6.1±2.8 2.9±2.2 12.3±12.0 7.2±6.6 6.0±2.0 5.7±1.8 5.3±1.6
 KBMANT Anterior 6.1±2.6 2.8±2.8 12.7±12.1 7.2±6.6 5.7±1.9
b 5.5±1.7a,b 5.1±1.5a,b
 KBMPOST Anterior 5.9±2.4 2.5±1.9 11.4±11.1 6.5±6.0 6.2±2.0
a,b 6.0±1.9a,b 5.6±1.8a,b
 Full KBM Posterior 12.8±5.3 6.8±3.7 13.8±9.1 7.8±9.1 9.8±3.1 8.9±2.8 8.0±2.5
 KBMANT Posterior 13.2±5.6
b 6.6±3.5 13.9±13.8 8.0±5.4 9.6±3.1 8.7±2.7 7.8±2.5
 KBMPOST Posterior 12.6±5.1
b 6.9±3.7 13.8±9.1 7.7±5.2 9.9±3.0 9.1±2.7 8.2±2.5
a Indicates a statistically significant difference between the studied model and the full KBM model.
b Indicates a statistically significant difference between the studied model and the complementary model.
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C.  Beam arrangement
During the initial phases of DVH estimation validation, the DVH estimates for the spinal 
cord and esophagus OARs for the VMAT technique for posterior lesions were found to be 
insufficient, resulting in estimates that were higher than the clinical plan. Upon conclusion 
of optimization and dose calculation, the spinal cord and esophagus structures in the KBM 
plan did not meet OAR constraints. However, plans validated using the IMRT technique had 
good estimates and were able to achieve OAR doses. The discrepancy in plan quality between 
the treatment techniques (IMRT vs. VMAT) was thought to be due to the differences in beam 
geometry, particularly for posterior lesions. After an additional five posterior VMAT lesions 
were added, for a total of 34 posterior cases in the full KBM, the DVH estimates were lowered 
to values within the clinical plan (Table 3). 
For plans created with seven- and nine-field templates, all OARs met the planning criteria. 
The nine-field beam arrangement resulted in lower spinal cord doses, 6.7 ± 2.9 Gy vs. 7.3 ± 
3.0 Gy (p = 0.05), compared to the seven-field arrangement. However, compared to the clinical 
plan, the nine-field beam arrangement resulted in higher doses to 0.035 cc (14.5 ± 10.1 Gy vs. 
13.3 ± 9.8 Gy, p = 0.01) and 15 cc (8.5 ± 6.5 Gy vs. 7.6 ± 5.6 Gy, p = 0.04) of the heart. The 
CI was comparable between the two template beam arrangements, however, the GI increased 
in the nine-field plans from 5.9 to 6.1 compared to the seven-field plans, p = 0.0001, as well as 
compared to the clinical plans’ GI of 5.9, p = 0.013.
 
IV. DISCUSSION
In this study, a lung SBRT KBM was created using a commercial DVH algorithm and validated 
for use on a variety of lesion locations, planning technique, and beam arrangements. Previous 
studies of KBMs on prostate, head and neck, and hepatocellular cancers have shown good results 
compared to clinically treated plans.(9-12) Less variability in beam arrangements and planning 
techniques are often seen in head and neck and prostate treatments, either using a seven- or 
nine-field static IMRT evenly spread out over 360° or a full arc VMAT technique. A variety 
of planning techniques are often used in lung SBRT treatments, and thus the model created in 
this study was evaluated to verify the robustness of the KBM, as well as for the clinical needs 
at our institution.
Often in SBRT, in addition to dosimetric constraints on volumetric percentages of the OARs, 
constraints are warranted for the maximum point dose of an OAR. During validation of the KBM, 
multiple KBPs did not meet the maximum point dose for multiple OARs. This was resolved by 
placing a manual objective and priority below the maximum allowable OAR dose. The KBM 
was revalidated to ensure the manual priority placed on the objective was adequate for differing 
patient geometries. For cases where the PTV abuts the OAR, the OAR maximum dose could 
not be met running the model independently. In order to achieve the OAR dose, several rounds 
of optimization with planner intervention were necessary. As a result, PTV coverage is often 
sacrificed in order to meet the OAR constraint. Although the model was trained with cases where 
the PTV abuts the OAR, this may be a limitation of the KBM algorithm. Furthermore, because 
the model was created based on the contouring criteria at our institution, where the PTV was 
manually modified to avoid overlap with the OARs, the principal component employed in this 
KBM is unable to model situations in which the OARs overlap with PTVs. This may limit the 
types of cases that the KBM can be applied to and may not be applicable to institutions that do 
not use the same contouring criteria. For complex cases, the benefit in efficiency of the KBP 
may be limited. Future studies include training the KBM with more difficult and complex cases 
to test if the model can learn to produce doses similar to those down with manual planning.
The full KBM was validated using both IMRT and VMAT techniques and resulted in fairly 
equivalent OAR doses with clinical IMRT and VMAT plans. Although more studies need to be 
performed, preliminary results of the validation plans show that the KBM can quickly achieve a 
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plan that is near equivalent in regard to OAR dose to the clinical plan with only one optimiza-
tion. In the case of the KBM validated on IMRT, the KBPs resulted in better OAR dose for the 
spinal cord compared to the clinical plan. However, the VMAT KBP resulted in higher doses to 
the esophagus. This may be due to the difference in beam geometry between IMRT and VMAT, 
where the gantry rotation is limited by machine. In the model training, more posterior VMAT 
plans were added to the model to compensate for the higher spinal cord dose, which may have 
resulted in a tradeoff between the spinal cord and esophagus doses in the model impacting the 
other lesion locations. It should be noted that, even though the OAR doses met the criteria, the 
dose distribution should be visually inspected to ensure dose conformity. The CIs for all plans 
were all very near an ideal CI of 1, however larger deviations occurred amongst the GIs. Both 
VMAT and IMRT KBPs resulted in larger GIs than the clinical plans. This may have been a 
result of the KBM optimizing the OAR doses too aggressively, resulting in a slightly skewed 
planar dose distributions, as well as the clinical plan being optimized using multiple iterations 
in conjunction with different planning techniques, such as optimization structures, to achieve 
a smaller gradient index.
When independent anterior and posterior KBMs were created, the KBMANT achieved better 
doses to the spinal cord compared to the full KBM, whereas the KBMPOST achieved better doses 
to the esophagus and heart compared to the KBMANT. Similarly for the central and peripheral 
models, the KBMP achieved better results for the esophagus than the KBMC. Originally it was 
thought that a posterior model would result in better spinal cord doses, and the central model 
would achieve better esophagus and heart doses due to the proximity of the PTV location to the 
OARs. Previous studies comparing three head and neck models show that the resulting OAR 
doses depend heavily on the type of cases that the model was trained with.(14) In our study, the 
sub-KBM where the distance between the OAR and PTV was smaller did not achieve lower 
doses to the OAR. The geometric PCAs for those plans may have been in the outer range of 
the model, and extrapolated for geometries where the distance between the OAR and PTV was 
large. In this study, the plans in the submodels were not replanned. This may have resulted in 
greater differences between the sub-KBMs; however, replanning all the training cases would 
have changed the training set drastically. Overall, the results of validation showed similar 
tradeoffs in OAR doses between the KBMANT and KBMPOST models and the KBMC and KBMP 
models. In the full KBM, all OARs benefit in the combined model. Differences between the full 
KBM and the sub-KBMs were minimal, less than 1 Gy, which may be clinically insignificant. 
When using beam templates, KBPs met all OAR constraints, although slight tradeoffs 
between the spinal cord and heart were observed. This may be due to the beam arrangements 
in the clinical plans which were purposely arranged so that beams did not enter through the 
cord or the heart. The optimizer and automated priorities were able to achieve OAR doses; 
however, with suboptimal beam placement, an increase in dose to OARs may be expected. 
Furthermore, the use of beam templates is common practice in many clinical settings. The 
combination of KBM and beam templates may allow for increased efficiency and throughput 
of plans.                                                                                                                                                                                                                                             
 
V. CONCLUSIONS
RapidPlan KBMs can be used to generate lung SBRT plans that are comparable to clinical 
plans. With sufficient model training and variability of patient geometry in the model, a KBM 
can be created to encompass both IMRT and VMAT techniques, differing tumor locations, and 
template beam arrangements.
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